Today's News |
|
Advantage Director Resigns From Board
Thursday, October 23, 2014
Vancouver, BC, October 23, 2014--(T-Net)--BC Advantage Funds (VCC) Ltd. announced today that it has received notice of resignation from one of its directors.
Robert W. (Bob) Rieder, CEO of ESSA Pharma Inc. and Chairman of Cardiome Pharma Corp., advised in the notice that he is resigning from the Advantage board in order to devote more time to ESSA and Cardiome.
Commented Advantage CEO, Frank Holler, "Advantage has, over the past two and a half years, had the benefit of Bob's substantial experience and knowledge in the technology sector. We are disappointed to lose him as a director of the company and wish him well with ESSA, Cardiome and his future endeavors".
About Advantage
BC Advantage Funds (VCC) Ltd. is a venture capital corporation, formed under the Small Business Venture Capital Act (British Columbia), to invest in emerging technology companies resident in British Columbia. For more information about Advantage, please visit our website at www.bcadvantagefunds.com.
Member Tools |
||||
View Company Website |
Share |
|||
|
Member Toolbar |
BC Advantage Funds (VCC) Ltd. Posted: Oct 23, 2014 |
News Actions |
Navigation |
Hiring Today |
|||||||||||||||||||
See All Jobs |
|||||||||||||||||||
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|